A Phase IV, Non comparative, Open label, Multicentric Trial to Evaluate the Safety and Efficacy of SYNRIAM® in the Treatment of Acute Uncomplicated Plasmodium vivax

Trial Profile

A Phase IV, Non comparative, Open label, Multicentric Trial to Evaluate the Safety and Efficacy of SYNRIAM® in the Treatment of Acute Uncomplicated Plasmodium vivax

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Arterolane/piperaquine (Primary)
  • Indications Malaria
  • Focus Adverse reactions
  • Sponsors Sun Pharmaceutical Industries
  • Most Recent Events

    • 06 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top